Sawbridgeworth, United Kingdom

Antonio Kuok Keong Vong


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Sawbridge, GB (2002)
  • Sawbridgeworth, GB (2002 - 2003)

Company Filing History:


Years Active: 2002-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Antonio Kuok Keong Vong: Innovator in Antipsychotic Research

Introduction

Antonio Kuok Keong Vong is a notable inventor based in Sawbridgeworth, GB. He has made significant contributions to the field of pharmacology, particularly in the development of antipsychotic agents. With a total of 3 patents to his name, Vong's work focuses on innovative compounds that target dopamine receptors.

Latest Patents

Vong's latest patents include groundbreaking research on Tetrahydrobenzazepine derivatives, which are useful as modulators of dopamine D3 receptors. This work aims to provide new avenues for antipsychotic treatments. Additionally, he has developed Tetraisoquinoline derivatives that also serve as modulators of dopamine D3 receptors, further expanding the potential for therapeutic applications in mental health.

Career Highlights

Antonio Vong is currently associated with SmithKline Beecham Corporation, where he continues to push the boundaries of pharmaceutical research. His innovative approach and dedication to improving mental health treatments have positioned him as a key figure in his field.

Collaborations

Vong has collaborated with esteemed colleagues such as Mervyn Thompson and Robert William Ward. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Antonio Kuok Keong Vong is a prominent inventor whose work in antipsychotic research is paving the way for future innovations in mental health treatment. His contributions are vital to the ongoing development of effective pharmacological solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…